Overview
Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder
Status:
Withdrawn
Withdrawn
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.Treatments:
p-Hydroxyamphetamine
Criteria
Inclusion Criteria:- Patients who have successfully completed the Phase III double-blind study.
Exclusion Criteria:
- Patients with serious adverse events or clinically significant adverse events in the
Phase III double-blind study.